Skip to main content
Past Event

Findings from a Mini-Sentinel Assessment: Rotavirus Vaccines and Risk of Intussusception

Past Event

Findings from a Mini-Sentinel Assessment: Rotavirus Vaccines and Risk of Intussusception

On July 23, the Engelberg Center for Health Care Reform at Brookings held a roundtable webinar, “Findings from a Mini-Sentinel Assessment: Rotavirus Vaccines and Risk of Intussusception”. This webinar highlighted a recent study which examined an association between rotavirus vaccinations and increased risk of intussusception in U.S. infants. Initiated by the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA), this study was conducted through the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) program, a component of the Mini-Sentinel pilot for active medical product surveillance.

Dr. Michael Nguyen, Deputy Director in the Division of Epidemiology at CBER, provided a brief description of the rationale for conducting this study and the FDA response to its findings. Dr. Katherine Yih, an epidemiologist and lecturer at Harvard Pilgrim Health Care Institute and Harvard Medical School, presented an overview of study methods, analysis, and results.

Agenda

Welcome and Introduction

Overview of Results from Mini-Sentinel Medical Product Assessment

Roundtable Discussion and Questions

FDA Opening Remarks

M

Michael Ngyuen

Deputy Director - Division of Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

More Information

More

Get a weekly events calendar from Brookings